Role of serum biomarkers to optimise a validated clinical risk prediction tool for gestational diabetes.
Sally K AbellSoulmaz ShorakaeJacqueline A BoyleBarbora De CourtenNigel K SteptoHelena J TeedeCheryce L HarrisonPublished in: The Australian & New Zealand journal of obstetrics & gynaecology (2018)
A two-step approach combining FG and HMW adiponectin to a validated clinical risk prediction tool improved sensitivity and predictive ability for ADIPS GDM. Further research is required to enhance GDM prediction using IADPSG criteria for application in clinical practice.